Dyne Therapeutics (DYN) Accumulated Depreciation (2019 - 2026)

Dyne Therapeutics (DYN) has 8 years of Accumulated Depreciation data on file, last reported at $9.2 million in Q1 2026.

• On a quarterly basis, Accumulated Depreciation rose 27.78% year-over-year to $9.2 million in Q1 2026; TTM through Mar 2026 was $9.2 million, a 27.78% increase from a year earlier, with the FY2025 full-year figure at $8.7 million, up 28.76% from the prior year.
• Accumulated Depreciation for Q1 2026 stood at $9.2 million, up from $8.7 million in the prior quarter.
• Over the last five years, Accumulated Depreciation for DYN reached as high as $9.2 million in Q1 2026 and fell as low as $2.4 million in Q1 2022.
• Historically, Accumulated Depreciation has averaged $5.7 million across 5 years, with a median of $5.7 million in 2024.
• Across the five-year window, Accumulated Depreciation jumped 95.3% in 2022 and grew 25.98% in 2025, its largest moves.
• Year by year, Accumulated Depreciation stood at $3.6 million in 2022, then surged by 45.72% to $5.3 million in 2023, then rose by 28.08% to $6.8 million in 2024, then grew by 28.76% to $8.7 million in 2025, then advanced by 5.13% to $9.2 million in 2026.
• Per Business Quant data, the three most recent Accumulated Depreciation figures were $9.2 million in Q1 2026, $8.7 million in Q4 2025, and $8.2 million in Q3 2025.